Amelioration of atherosclerosis by tanshinone IIA in hyperlipidemic rabbits through attenuation of oxidative stress

European Journal of Pharmacology

Volumn 674, Issue 2-3, 2012, Pages 359-364

  Chen, Wenying ^a   Tang, Futian ^b   Xie, Bailu ^a   Chen, Shaorui ^c   Huang, Heqing ^c   Liu, Peiqing ^c  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

Atherosclerosis; Glutathione peroxidase; Oxidized low density lipoprotein; Superoxide dismutase; Tanshinone IIA

Indexed keywords

GLUTATHIONE PEROXIDASE; LIPID; LIPID PEROXIDE; MALONALDEHYDE; OXIDIZED LOW DENSITY LIPOPROTEIN; SUPEROXIDE DISMUTASE; TANSHINONE IIA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; AORTA ATHEROSCLEROSIS; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVITY; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RABBIT;

ANIMALS; ANTIOXIDANTS; AORTA, THORACIC; ATHEROSCLEROSIS; CHOLESTEROL; DISEASE PROGRESSION; DITERPENES, ABIETANE; GLUTATHIONE PEROXIDASE; HYPERLIPIDEMIAS; LIPOPROTEINS, LDL; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; RABBITS; SUPEROXIDE DISMUTASE;

EID: 84855545432     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.10.040     Document Type: Article

References (19)

1. Anselmi, M., Garbin, U., Agostoni, P., Fusaro, M., Pasini, A.F., Nava, C., Keta, D., Turri, M., Zardini, P., Vassanelli, C., Lo, Cascio V., Cominacini, L., 2006. Plasma levels of oxidized-low-density lipoproteins are higher in patients with unstable angina and correlated with angiographic coronary complex plaques. Atherosclerosis 185, 114-120. (Pubitemid 43117557)
2. Cai, H., Harrison, D.G., 2000. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 87, 840-844.
3. Dominguez-Rodriguez, A., Abreu-Gonzalez, P., Garcia-Gonzalez, M., Ferrer-Hita, J., Vargas, M., Reiter, R.J., 2005. Elevated levels of oxidized low-density lipoprotein and impaired nocturnal synthesis of melatonin in patients with myocardial infarction. Atherosclerosis 180, 101-105.
4. Eugene, J., McColgan, S.J., Pollock, M.E., Hammer-Wilson, M., Moore-Jeffries, E.W., Berns, M.W., 1985. Experimental arteriosclerosis treated by conventional and laser endarterectomy. J. Surg. Res. 39, 31-38. (Pubitemid 16191062)
5. Fu, J., Huang, H., Liu, J., Pi, R., Chen, J., Liu, P., 2007. Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis. Eur. J. Pharmacol. 30, 213-221. (Pubitemid 46976900)
6. Jayaraman, S., Gantz, D.L., Gursky, O., 2007. Effects of oxidation on the structure and stability of human low-density lipoprotein. Biochemistry 46, 5790-5797. (Pubitemid 46764127)
7. Kleemann, R., Princen, H.M., Emeis, J.J., Jukema, J.W., Fontijn, R.D., Horrevoets, A.J., Kooistra, T., Havekes, L.M., 2003. Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol-lowering effect in APOE*3-Leiden transgenic mice: evidence for antiinflammatory effects of rosuvastatin. Circulation 108, 1368-1374. (Pubitemid 37174416)
8. Lin, M.S., Hsu, H.C., Lin, L.C., Li, H.Y., Lee, B.C., Lee, Y.T., Chen, M.F., 2007. Higher glutathione peroxidase expression in thoracic aorta as a protective factor against oxidative stress and atherosclerosis in rabbits. Cardiology 108, 381-386.
9. Meisinger, C., Baumert, J., Khuseyinova, N., Loewel, H., Koenig, W., 2005. Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population. Circulation 112, 651-657. (Pubitemid 41099043)
10. Niu, X.L., Ichimori, K., Yang, X., Hirota, Y., Hoshiai, K., Li, M., Nakazawa, H., 2000. Tanshinone II-A inhibits low density lipoprotein oxidation in vitro. Free Radic. Res. 33, 305-312.
11. Rosenblat, M., Coleman, R., Aviram, M., 2002. Increased macrophage glutathione content reduces cell-mediated oxidation of LDL and atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 163, 17-28. (Pubitemid 34615722)
12. Rutishauser, J., 2006. The role of statins in clinical medicine-LDL-cholesterol lowering and beyond. Swiss Med. Wkly. 136, 41-49. (Pubitemid 43266611)
13. Tang, F., Wu, X., Wang, T., Wang, P., Li, R., Zhang, H., Gao, J., Chen, S., Bao, L., Huang, H., Liu, P., 2007. Tanshinone II A attenuates atherosclerotic calcification in rat model by inhibition of oxidative stress. Vascul. Pharmacol. 46, 427-438. (Pubitemid 46552282)
14. Tang, F.T., Cao, Y., Wang, T.Q., Wang, L.J., Guo, J., Zhou, X.S., Xu, S.W., Liu, W.H., Liu, P.Q., Huang, H.Q., 2010. Tanshinone IIA attenuates atherosclerosis in ApoE(-/-) mice through down-regulation of scavenger receptor expression. Eur. J. Pharmacol. 10, 275-284.
15. Yeung, A.C., Tsao, P., 2002. Statin therapy: beyond cholesterol lowering and antiinflammatory effects. Circulation 105, 2937-2938. (Pubitemid 34693821)
16. Verreth, W., De Keyzer, D., Davey, P.C., Geeraert, B., Mertens, A., Herregods, M.C., Smith, G., Desjardins, F., Balligand, J.L., Holvoet, P., 2007. Rosuvastatin restores superoxide dismutase expression and inhibits accumulation of oxidized LDL in the aortic arch of obese dyslipidemic mice. Br. J. Pharmacol. 151, 347-355. (Pubitemid 46842672)
17. Victor, V.M., Apostolova, N., Herance, R., Hernandez-Mijares, A., Rocha,M., 2009. Oxidative stress and mitochondrial dysfunction in atherosclerosis: mitochondria-targeted antioxidants as potential therapy. Curr. Med. Chem. 16, 4654-4667.
18. Wang, H.H., Hung, T.M., Wei, J., Chiang, A.N., 2004. Fish oil increases antioxidant enzyme activities in macrophages and reduces atherosclerotic lesions in apoE-knockout mice. Cardiovasc. Res. 61, 169-176. (Pubitemid 38056693)
19. Witztum, J.L., Steinberg, D., 2001. The oxidative modification hypothesis of atherosclerosis: does it hold for humans? Trends Cardiovasc. Med. 11, 93-102. (Pubitemid 33070331)